2017 International Bio-Pharmaceutical Industry Forum

Agenda

 

 

September 15 | Multi-function Convention Hall (A), 3rd Floor
 

Theme: How will China’s Pharmaceutical Enterprises be in line with International

Standards after Entering ICH?

Moderator

Xu Haiying, Director of Operation of Health Industry Division of China Merchants Group

Time

Guest Speaker

Speech topic

13:30-14:00

Nobel Prize Winner, Robert C. Merton; Zhao Gang, Researcher of Strategy Research Institute of the Ministry of Science and Technology; Pan Guangcheng, Executive Director of China Pharmaceutical Industry Association

Opening Ceremony

14:00-14:20

Wu Haidong, Vice Director of Consumer Goods Industry Division of the Ministry of Industry and Information Technology

Interpretation of the Thirteenth Five-Year Development Plan for China’s Pharmaceutical Industry

14:20-14:40

Zhang Ziran, Vice Director of China Pharmaceutical Industry Association

Opportunities of Investment Mergers and Acquisitions under New Pharmaceutical Policy

14:40-15:00

Zuo Min, President of Shanghai Pharmaceuticals Holding Co., Ltd.

Internationalization - A Nirvana for Chinese Medicine Enterprises

15:00-15:20

Chen Su, Vice President of Kanghong Pharmaceutical

Internationalization Course of China’s Innovative Medicine “Research and Development Course of Conbercept”

15:20-15:30

Coffee / tea break

15:30-15:50

Lu Yun, President of Hengrui Medicine Research Institute

Significance and Application of ICH Guidelines in Research and Development of New Drugs

15:50-16:10

An Liang, Executive Vice President of Qingdao Huanghai Pharmaceutical Co., Ltd.

Chances and Challenges Faced by China’s Pharmaceutical Enterprises after Entering ICH

16:10-16:30

Yang Sheng, Vice Director of Department of Drug and Cosmetics Registration (Department of TCMs and Ethno-Medicines Supervision)

Current Drug Registration System Reform

16:30-16:50

Jiang Biao – Vice President of Shanghai Advanced Research Institute, Chinese Academy of Sciences

From Traditional Natural Products to Discovery of Modern Immunochemicals

16:50-17:50

Yang Sheng, Vice Director of Department of Drug and Cosmetics Registration (Department of TCMs and Ethno-Medicines Supervision) of CFDA;

Nobel Prize Winners, Randy W. Schekman and Moshe Szyf;

Zhou Demin, Dean of School of Pharmaceutical Sciences of Peking University;

Yang Suming, Chairman of the Board of Directors of Sino-American Shanghai Squibb Pharmaceuticals Ltd.;

Zhang Dan, Chairman of the Board of Directors of Fountain Medical Development Ltd.;

Ma Jialie, Managing Director of Investment Banking Operations Committee of Zhongtai Securities Co., Ltd.

Dialogue Topic: How will China’s pharmaceutical industry be internationalized after entering ICH?

Moderator: Gong Zhaolong, Former FDA Official, CEO of 3D Medicines

18:30-20:00

Banquet

September 16 | Multi-function Convention Hall (A), 3rd Floor

Theme: Internationalization of Pharmaceutical Industry

Moderator

Zhang Yue, Partner of BioVeda China Fund (BVCF)

Time

Guest Speaker

Speech topic

09:00-09:20

Guo Ying, Vice General Manager of Investment Banking Division of Ping An Securities

Brief Analysis over Transnational Mergers and Acquisitions

09:20-09:40

Wang Ying, General Manager of Beijing Changping Technology Innodevelop Group

Promoting Transformation of Hard Science and Technology by One-stop Service

09:40-10:00

Yu Rong, Chairman of the Board of Directors of Meinian Onehealth Healthcare (Group) Co., Ltd.

Healthcare Industry Trends and Meinian's Path Choice

10:00-10:20

Hu Jiangbin, Vice General Manager of Huahai Pharmaceutical Co., Ltd. and Senior Vice President of Huahai Pharmaceutical Co., Ltd. US Branch

Keep Pace with International Standards, Build Presence in European and American High-end Preparation Markets

10:20-10:35

Coffee / tea break

10:35-11:35

Liu Liedong, Deputy Mayor of Chengdu;

Nobel Prize Winner, Zhu Diwen;

Fellow Hong Mingqi, Vice President of MD Anderson Cancer Center of University of Texas;

Zhao Gang, Researcher of Strategy Research Institute of the Ministry of Science and Technology;

Zhang Yizhuo, General Manager in charge of Investment of Huapont Life Sciences Co., Ltd.

Dialogue Topic: How will Technical Innovation be Industrialized?

Moderator: Kang Wei, Vice General Manager of Fresenius Kabi

12:00-13:00

Lunch

Theme: Industrialization and Internationalization of Scientific and Technological Achievements

Moderator: Lu Lirong, Vice President of Lingchuang Financial Capital of Zhongguancun Development Group

13:00-13:20

Feng Hao, Vice President and Board Secretary of Kelun Pharmaceutical

Introduction of Kazakhstan Project of Kelun Group (Kelun KAZ)

13:20-13:40

Gong Yong, Director of Marketing and Sales of China Region of DSM Sinochem Pharmaceuticals Co., Ltd. and General Manager of DSM Sinochem Pharmaceuticals (Zibo)

Co., Ltd.

A Path towards Sustainable Development of Antibiotic Industry

13:40-14:00

Hong Zhi, Senior Vice President of Global R&D of GSK Anti-infective Diseases Field

Global Public Health: About China’s Leadership

14:00-14:15

Coffee / tea break

14:15-15:15

Nobel Prize Winner, Robert C. Merton;

Jiang Weina, Chief Analyst on Pharma Industry of Guosen Securities;

Zuo Min, President of Shanghai Pharmaceuticals Holding Co., Ltd.;

Yu Rong, Chairman of the Board of Directors of Meinian Onehealth Healthcare (Group) Co., Ltd.;

Shuang Rongqing, Chairman of the Board of Directors of the Balloch Group (PE);

Chen Mingjian, Founder of Hollyhigh Capital

Dialogue Topic: Internationalization of Pharmaceutical Investment Mergers and Acquisitions

Moderator: He Xing, Founding Partner of HighLight Capital

15:15-15:45

Awarding ceremony and closing ceremony


Home | About ISSCNL | Contact Us | © ISSCNL 2017 | Connect With Us: